Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma

Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma

Abstract is missing (Short communication)

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta dermato-venereologica 2022-02, Vol.102, p.adv00650-adv00650
Hauptverfasser: Batinac, Tanja, Hlača, Nika, Simetić, Luka, Valković, Frane, Peternel, Sandra, Prpić-Massari, Larisa
Format: Artikel
Sprache:eng
Schlagworte:
anemia
Anemia - chemically induced
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols - adverse effects
Azetidines
cobimetinib
Humans
melanoma
Melanoma - drug therapy
Melanoma - pathology
pembrolizumab
Piperidines
Proto-Oncogene Proteins B-raf - genetics
Short Communication
Skin Neoplasms - drug therapy
Skin Neoplasms - pathology
Stevens-Johnson syndrome
Stevens-Johnson Syndrome - diagnosis
Stevens-Johnson Syndrome - etiology
vemurafenib
Vemurafenib - adverse effects
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract is missing (Short communication)
ISSN:0001-5555
1651-2057
DOI:10.2340/actadv.v102.1433